How Much Did SkinVision Raise?
Funding & Key Investors

SkinVision, a prominent player in digital health and skin cancer detection, has secured significant enterprise-level funding, with its total funding reaching $11M. The company recently announced a major strategic investment of $7.6M, underscoring its continued growth and market traction in the health technology sector.

What is SkinVision?

SkinVision
SoftwareHealthcare Software

SkinVision operates as a mobile application dedicated to providing accurate and timely skin cancer detection. Leveraging advanced AI technology, coupled with oversight from dermatologists, the app offers personalized skin health advice and health path recommendations. Clinically validated and trusted by over 3 million users globally, SkinVision empowers individuals to proactively manage their skin health, particularly those at risk from sun exposure. The platform serves as a crucial link between customers, doctors, and insurers, aiming to optimize skin health outcomes and enhance the early detection of skin cancer.

How much funding has SkinVision raised?

SkinVision has raised a total of $11M across 2 funding rounds:

2015

Unspecified

$3.4M

2018

Unspecified

$7.6M

Unspecified (2015): $3.4M with participation from LEO Pharma and Personal Health Solutions Capital

Unspecified (2018): $7.6M led by PHS Fund and LEO Pharma

Key Investors in SkinVision

LEO Pharma

LEO Pharma is a multinational Danish pharmaceutical company with a specialization in dermatology, contributing significant expertise to SkinVision's health-tech advancements.

Personal Health Solutions Capital

Personal Health Solutions Capital is an investment firm focused on the consumer health and well-being market, supporting technology-enabled solutions that enhance quality of life and reduce chronic illness risk.

PHS Fund

Undisclosed investor participating in the funding round, likely aligned with health and wellness sector investments.

What's next for SkinVision?

The recent major strategic investment signifies a pivotal moment for SkinVision, likely enabling the company to accelerate its product development, expand its user base, and further integrate its AI-driven dermatological insights into broader healthcare ecosystems. This capital infusion is expected to bolster its position in the competitive health tech market, potentially leading to new partnerships and enhanced service offerings for both consumers and medical professionals. The company's focus on early detection and proactive skin health management aligns with growing global health trends, positioning it for sustained expansion and impact.

See full SkinVision company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

SoftwareSupply Chain Management (SCM) Software
Customer Engagement PlatformsSoftwareBusiness Intelligence (BI) Software
Healthcare SoftwareSoftware
Business Intelligence (BI) SoftwareSoftware

Frequently Asked Questions Regarding SkinVision Financial Insights

What are the most recent funding rounds that SkinVision has completed, and what were the funding rounds?
SkinVision has recently completed 2 funding rounds: Unspecified on Jul 30, 2018, Unspecified on Aug 22, 2015.
What is the total amount of funding SkinVision has raised to date?
SkinVision has raised a total of $11M in funding to date.
How many funding rounds has SkinVision completed?
SkinVision has completed 2 funding rounds.
How much funding did SkinVision raise in its most recent funding round?
SkinVision raised $7.6M in its most recent funding round.
Who are the lead investors in SkinVision's latest funding round?
The lead investor in SkinVision's latest funding round was PHS Fund. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in SkinVision's history?
The largest funding round in SkinVision's history was $7.6M.
See more information about SkinVision